ArticleJournal of cellular and molecular medicine2019

Telmisartan cardioprotects from the ischaemic/hypoxic damage through a miR-1-dependent pathway.

Maria Consiglia Trotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.